SCIEX and New Objective Announce Partnership to Provide Advanced Nanospray Ionization Technologies for Next-Generation Proteomics

New nanospray sources to offer maximum sensitivity and robustness for NanoLC-MS

May 26, 2015

Framingham, MA — SCIEX, a global leader in analytical technologies, today announced a partnership with an industry leader in innovative nanospray technology, New Objective, Inc. that will enable SCIEX to offer the New Objective Digital PicoView® 450 Source for use with the latest generation SCIEX mass spectrometry systems. These high performance nanospray ionization sources offer maximum sensitivity for researchers working with precious samples, and are particularly suitable for proteomics researchers using the SCIEX TripleTOF® 6600 Next-Generation Proteomics System.

Nanospray ion sources are widely used for high sensitivity LC-MS applications, supporting researchers needing to analyze limited amounts of biological samples. Challenges in qualitative and quantitative analysis demand high performance in long-term robustness and spray stability. The New Objective Digital PicoView 450 is a digitally controlled, flexible and reliable nanospray source that provides consistent high performance and meaningful results, allowing researchers to spend less time benchmarking and, instead, reach scientific answers more quickly.

Reid Townsend, M.D., Ph.D., Professor of Medicine and Director, Mass Spectrometry Resource at Washington University, St. Louis, has been testing the Digital PicoView 450 Source. He commented, "We have used New Objective PicoView nano-sources for over a decade and Digital PicoView sources for 7 years. We have found them suitable for 24/7 operation for 2-3 week blocks of continuous LC-MS analysis. Ease of spray visualization is an impressive feature. This (Digital PicoView) is the most stable, robust nanospray set-up I've ever had".

"By bringing together these two leading companies in mass spectrometry and nanospray technology we will continue to provide the most advanced workflows in life science research; SCIEX is very proud to be a part of this," said Aaron Hudson, Senior Director of Academic and Clinical Research Business of SCIEX.

"At New Objective we build strong customer relationships scientist-to-scientist and strive to provide innovative, enabling solutions," said Gary Valaskovic, Ph.D., President and co-founder of New Objective. "Partnering with SCIEX is a great opportunity for us to forge new relationships through their market leading position in quantitative analysis."

This partnership is the latest in SCIEX’s continuous commitment to provide life science researchers with innovative solutions to further their Omics research.

Learn more about the Digital PicoView Nanospray Ion Source

About SCIEX

SCIEX helps to improve the world we live in by enabling scientists and laboratory analysts to find answers to the complex analytical challenges they face. The company's global leadership and world-class service and support in the capillary electrophoresis and liquid chromatography-mass spectrometry industry have made it a trusted partner to thousands of the scientists and lab analysts worldwide who are focused on basic research, drug discovery and development, food and environmental testing, forensics and clinical research.

With over 40 years of proven innovation, SCIEX excels by listening to and understanding the ever-evolving needs of its customers to develop reliable, sensitive and intuitive solutions that continue to redefine what is achievable in routine and complex analysis. For more information, please visit sciex.com

SCIEX social: @SCIEXnewsLinkedIn, and Facebook.

Contact Information
Lulu VanZandt
Program Manager, Brand, Public Relations and Social Media, SCIEX
lulu.vanzandt@sciex.com
+1 (508) 383-7163
M: +1 (508) 782-9484

AB Sciex is operating as SCIEX.
© 2018 AB Sciex. The trademarks mentioned herein are the property of the AB Sciex Pte. Ltd. or their respective owners. AB Sciex™ is being used under license.

For research use only. Not for use in diagnostic procedures.